Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-23-011881
Filing Date
2023-07-14
Accepted
2023-07-14 07:55:22
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 tmb-20230714x424b3.htm 424B3 582496
2 GRAPHIC tmb-20230714x424b3_a001.jpg GRAPHIC 7083
3 GRAPHIC tmb-20230714x424b3_c001.jpg GRAPHIC 3551
4 GRAPHIC tmb-20230714x424b3_c002.jpg GRAPHIC 7542
5 GRAPHIC tmb-20230714x424b3_c003.jpg GRAPHIC 3384
6 GRAPHIC tmb-20230714x424b3_c004.jpg GRAPHIC 14958
7 GRAPHIC tmb-20230714x424b3_c009.jpg GRAPHIC 5668
  Complete submission text file 0001558370-23-011881.txt   642654
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-268103 | Film No.: 231088047
SIC: 2834 Pharmaceutical Preparations